Leede Financial Issues Optimistic Estimate for QIPT Earnings

Key Points

• Leede Financial has raised its FY2025 earnings per share estimate for Quipt Home Medical to ($0.28), up from a previous estimate of ($0.33).
• Quipt Home Medical reported quarterly earnings of ($0.07) per share, missing the consensus estimate of $0.03 by ($0.10).
• Several brokerages have revised their ratings for QIPT, with Benchmark maintaining a "buy" rating but lowering its price target from $6.00 to $4.00.

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Equities researchers at Leede Financial upped their FY2025 earnings per share (EPS) estimates for Quipt Home Medical in a research note issued to investors on Tuesday, August 12th. Leede Financial analyst D. Loe now anticipates that the company will post earnings of ($0.28) per share for the year, up from their previous forecast of ($0.33). The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Leede Financial also issued estimates for Quipt Home Medical's FY2026 earnings at ($0.04) EPS and FY2027 earnings at $0.09 EPS.

QIPT has been the topic of a number of other research reports. Wall Street Zen raised Quipt Home Medical from a "sell" rating to a "hold" rating in a research note on Saturday. Benchmark reaffirmed a "buy" rating and set a $4.00 target price (down previously from $6.00) on shares of Quipt Home Medical in a research note on Wednesday, May 14th. Finally, Canaccord Genuity Group upped their target price on Quipt Home Medical from $1.70 to $2.30 and gave the company a "hold" rating in a research note on Tuesday. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, Quipt Home Medical presently has an average rating of "Moderate Buy" and an average target price of $3.15.

Quipt Home Medical Trading Up 3.7%

NASDAQ QIPT traded up $0.08 during trading hours on Friday, hitting $2.25. 442,399 shares of the company were exchanged, compared to its average volume of 531,332. The stock has a 50-day moving average price of $2.02 and a 200 day moving average price of $2.17. The company has a quick ratio of 0.75, a current ratio of 1.15 and a debt-to-equity ratio of 0.71. Quipt Home Medical has a 52 week low of $1.35 and a 52 week high of $3.27. The stock has a market cap of $97.75 million, a PE ratio of -9.37 and a beta of 0.59.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings data on Monday, August 11th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.10). Quipt Home Medical had a negative return on equity of 9.78% and a negative net margin of 4.30%.The company had revenue of $58.30 million for the quarter, compared to the consensus estimate of $80.37 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of QIPT. JPMorgan Chase & Co. grew its stake in Quipt Home Medical by 241.3% in the fourth quarter. JPMorgan Chase & Co. now owns 103,753 shares of the company's stock worth $316,000 after purchasing an additional 73,350 shares in the last quarter. Geode Capital Management LLC grew its stake in Quipt Home Medical by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 512,304 shares of the company's stock worth $1,563,000 after purchasing an additional 4,242 shares in the last quarter. Wells Fargo & Company MN grew its stake in Quipt Home Medical by 30.9% in the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company's stock worth $73,000 after purchasing an additional 5,625 shares in the last quarter. Russell Investments Group Ltd. grew its stake in Quipt Home Medical by 14.3% in the fourth quarter. Russell Investments Group Ltd. now owns 910,618 shares of the company's stock worth $2,777,000 after purchasing an additional 113,682 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in Quipt Home Medical by 6.1% in the fourth quarter. Renaissance Technologies LLC now owns 229,600 shares of the company's stock worth $700,000 after purchasing an additional 13,300 shares in the last quarter. Institutional investors own 42.85% of the company's stock.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.